Diabetes multimorbidity and a voice diary app to help self-manage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial examines the feasibility of adapting and using the Fabla-diabetesMM audio diary app with 30 older adults who have diabetes and at least one other chronic condition. It also looks at whether using the app influences self-management outcomes. The study uses REDCap surveys alongside the audio diary to capture usability and health-management data. This research aims to describe how multimorbidity affects daily diabetes management and the patient experience. The setting is Emory Healthcare in Atlanta, led by Emory University.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed type 1 or 2 diabetes and at least one comorbidity (eg, obesity, HIV, heart failure, polycystic ovary syndrome, obstructive sleep apnea, and prediabetes with and without hypertension)
* Being able to fill in the Redcap surveys, and install and use the audio diary app.

Exclusion Criteria:

•Those who cannot use (e.g., no mobile phone, incompatible system), read, type, speak, or understand English in Redcap or the audio diary mobile app.

Where it's running

• Emory Healthcare
  Atlanta, Georgia, United States Recruiting

Study contacts

• Principal investigator: Wenhui Zhang, PhD — Emory University
• Study coordinator: Wenhui Zhang, PhD
• Email: wenhui.zhang@emory.edu
• Phone: 762-499-0411

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• Eversense Gemini system with new flash glucose feature — testing accuracy and safety

  This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.

  Recruiting Senseonics, Inc. · Escondido, California · NCT07386340

• Evaluating LY4057996 in Healthy Individuals and Those with Type 1 and Type 2 Diabetes

  This study is testing a new drug called LY4057996 to see how well it is tolerated and what side effects it might have in healthy people and those with Type 1 or Type 2 diabetes.

  Recruiting Phase 1 Eli Lilly and Company · Neuss · NCT06945406

• Comparing single-session and multiple-session laser treatment for diabetic eye disease

  This study is testing whether one session or multiple sessions of laser treatment works better for people with newly diagnosed diabetic eye disease to help them keep their vision and avoid complications.

  Recruiting Vastra Gotaland Region · Mölndal · NCT06549023

• Program to reduce food insecurity for hospitalized diabetics

  This study tests whether providing better access to healthy meals and nutrition education can help hospitalized patients with diabetes feel better and improve their overall health.

  Recruiting Stanford University · Palo Alto, California · NCT06329375

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.